Somite Therapeutics
Latest round
- Series A
Last raised
- May 2025
Total raised
- $48M
Investors
- 8
About Somite Therapeutics
Based in Massachusetts, US, and founded in 2023, Somite Therapeutics, Inc. operates as a biotechnology research company that uses AI to produce human tissue for cell therapies, ultimately aiming to cure various diseases by addressing cell population deficiencies. The company was co-founded by Micha Breakstone (CEO), Allon Klein, and Cliff Tabin. In May 2025, Somite Therapeutics, Inc. The company's AlphaStem platform focuses on developing AI foundation models to create human tissue at scale for diseases like diabetes, obesity, and muscular dystrophies. Somite's innovative approach involves building digital twins of the embryo, which are computational models mirroring real embryonic development, to guide cell differentiation protocols and optimize production variability in cell replacement therapies.
Who invested in Somite Therapeutics
8 investors across 1 round
See all investors in Somite Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 13, 2025
Amount
$48M
Investors
Questions about Somite Therapeutics
Who invested in Somite Therapeutics?
Somite Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Somite Therapeutics raised?
Somite Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Somite Therapeutics last raise money?
Somite Therapeutics's most recent round on record is a Series A, in May 2025.
What does Somite Therapeutics do?
Based in Massachusetts, US, and founded in 2023, Somite Therapeutics, Inc.
Where is Somite Therapeutics headquartered?
Somite Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Somite Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Somite Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Somite Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.